Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative analysis of cholera serum vibriocidal antibodies from Convalescent and vaccinated adults in Zambia.
Ng'ombe H, Bosomprah S, Phiri B, Muchimba M, Liswaniso F, Chibuye M, Luchen CC, Chibesa K, Musukuma-Chifulo K, Mwape K, Tigere S, Silwamba S, Sinkala A, Simuyandi M, Mbewe N, Kapaya F, Cunningham AF, Chilengi R, Sack D, Chisenga CC. Ng'ombe H, et al. Among authors: chibuye m. Vaccine. 2024 Aug 13;42(20):125979. doi: 10.1016/j.vaccine.2024.05.027. Epub 2024 May 17. Vaccine. 2024. PMID: 38760271
The Incidence and Risk Factors for Enterotoxigenic E. coli Diarrheal Disease in Children under Three Years Old in Lusaka, Zambia.
Sukwa N, Bosomprah S, Somwe P, Muyoyeta M, Mwape K, Chibesa K, Luchen CC, Silwamba S, Mulenga B, Munyinda M, Muzazu S, Chirwa M, Chibuye M, Simuyandi M, Chilengi R, Svennerholm AM. Sukwa N, et al. Among authors: chibuye m. Microorganisms. 2024 Mar 29;12(4):698. doi: 10.3390/microorganisms12040698. Microorganisms. 2024. PMID: 38674642 Free PMC article.
Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0-36 Months in Peri-Urban Areas of Lusaka.
Mwape K, Bosomprah S, Chibesa K, Silwamba S, Luchen CC, Sukwa N, Mubanga C, Phiri B, Chibuye M, Liswaniso F, Somwe P, Chilyabanyama O, Chisenga CC, Muyoyeta M, Simuyandi M, Barnard TG, Chilengi R. Mwape K, et al. Among authors: chibuye m. Microorganisms. 2023 Nov 17;11(11):2790. doi: 10.3390/microorganisms11112790. Microorganisms. 2023. PMID: 38004801 Free PMC article.
Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach.
Mwila-Kazimbaya K, Bosomprah S, Chilyabanyama ON, Chisenga CC, Chibuye M, Laban NM, Simuyandi M, Huffer B Jr, Iturriza-Gomara M, Choy RKM, Chilengi R. Mwila-Kazimbaya K, et al. Among authors: chibuye m. PLoS One. 2023 Nov 17;18(11):e0293101. doi: 10.1371/journal.pone.0293101. eCollection 2023. PLoS One. 2023. PMID: 37976323 Free PMC article.
Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial.
Sukwa N, Mubanga C, Hatyoka LM, Chilyabanyama ON, Chibuye M, Mundia S, Munyinda M, Kamuti E, Siyambango M, Badiozzaman S, Bosomprah S, Carlin N, Kaim J, Sjöstrand B, Simuyandi M, Chilengi R, Svennerholm AM. Sukwa N, et al. Among authors: chibuye m. Vaccine. 2023 Nov 2;41(46):6884-6894. doi: 10.1016/j.vaccine.2023.09.052. Epub 2023 Oct 12. Vaccine. 2023. PMID: 37838479 Free article. Clinical Trial.
Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (RotarixTM) Immunogenicity among Infants in Zambia.
Chauwa A, Bosomprah S, Laban NM, Phiri B, Chibuye M, Chilyabanyama ON, Munsaka S, Simuyandi M, Mwape I, Mubanga C, Chobe MC, Chisenga C, Chilengi R. Chauwa A, et al. Among authors: chibuye m. Vaccines (Basel). 2023 Jul 31;11(8):1303. doi: 10.3390/vaccines11081303. Vaccines (Basel). 2023. PMID: 37631871 Free PMC article.
Depression-Mediating Pathways From Household Adversity to Antiretroviral Therapy Nonadherence Among Children and Adolescents Living With HIV in Zambia: A Structural Equation Modeling Approach.
Rosen JG, Mbizvo MT, Phiri L, Chibuye M, Namukonda ES, Kayeyi N. Rosen JG, et al. Among authors: chibuye m. J Acquir Immune Defic Syndr. 2023 Jul 1;93(3):191-198. doi: 10.1097/QAI.0000000000003193. J Acquir Immune Defic Syndr. 2023. PMID: 36976552 Free PMC article.
Evaluation of ROTARIX® Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial.
Laban NM, Bosomprah S, Simuyandi M, Chibuye M, Chauwa A, Chirwa-Chobe M, Sukwa N, Chipeta C, Velu R, Njekwa K, Mubanga C, Mwape I, Goodier MR, Chilengi R. Laban NM, et al. Among authors: chibuye m. Vaccines (Basel). 2023 Feb 3;11(2):346. doi: 10.3390/vaccines11020346. Vaccines (Basel). 2023. PMID: 36851224 Free PMC article.
15 results